Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

The increase in weight loss with ... Reduction Act. Tirzepatide will be protected from inclusion in the negotiation list until 2030, as it was first approved in 2022, while semaglutide has been ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...

Boston, MA—Boston Plastic Surgery is pleased to announce the introduction of GLP-1 weight loss injections with semaglutide and tirzepatide, to its suite of wellness services. With this addition ...